Timothy Robinson

About

Timothy Robinson is a Lector in Greek and Latin at Yale University, where he received his PhD in Classics in 1994 with fellowships from Javits and Mellon. He has taught in several departments at Yale and is currently engaged in studies of Euripidean and Senecan tragedy. His field includes language instruction in Latin and Greek literature, with a specialization in Greek and Latin poetry. Robinson's research focuses on classical literature, particularly poetic works, and he has contributed to the understanding of adaptations of Sapphic strophe, the interpretation of monsters in Seneca's Apocolocyntosis, and the analysis of textiles and pretexts in Catullus' Carmen 64.

Research topics

• Medicine
• Internal medicine
• Oncology
• Biology
• Cancer research

Selected publications

• Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study

  Neuro-Oncology · 2020-11-07 · 109 citations

  articleOpen access

  BACKGROUND: Radiotherapy may synergize with programmed cell death 1 (PD1)/PD1 ligand (PD-L1) blockade. The purpose of this study was to determine the recommended phase II dose, safety/tolerability, and preliminary efficacy of combining pembrolizumab, an anti-PD1 monoclonal antibody, with hypofractionated stereotactic irradiation (HFSRT) and bevacizumab in patients with recurrent high-grade gliomas (HGGs). METHODS: Eligible subjects with recurrent glioblastoma or anaplastic astrocytoma were treat…

  PublisherOA PDFDOI

• Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).

  Journal of Clinical Oncology · 2020-05-20 · 59 citations

  article

  2501 Background: MTX-based chemoradiotherapy is effective in PCNSL, but carries a risk of severe neurotoxicity (NT), especially in the elderly. In a phase II single arm study, R-MPV-A chemotherapy was combined with substantially reduced doses of radiotherapy (23.4 Gy), achieving prolonged progression free survival (PFS) and overall survival (OS) with acceptable NT. Because R-MPV-A had never been tested without radiotherapy, we conducted a randomized study to determine if the low doses of radiati…

  PublisherDOI

• The Role of Radiotherapy in Lymphoma Patients Undergoing CAR T Therapy: Past, Present, and Future

  Seminars in Radiation Oncology · 2024-12-12 · 12 citations

  reviewOpen accessSenior authorCorresponding

  Chimeric antigen receptor (CAR) T-cell receptor therapy has transformed outcomes for patients with relapsed and refractory diffuse large B-cell lymphoma (R/R DLBCL). It is currently approved in the third line for all patients and in the second line for early relapsed or primary refractory disease. Although CAR T cell therapy offers the potential for improved outcomes, its use may also include logistical delays related to referral, medical, social, and financial clearance as well as manufacturing…

  PublisherDOI

• Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study

  Blood Advances · 2025-04-09 · 8 citations

  articleOpen access

  ABSTRACT: Despite the increasing utilization of bridging radiotherapy (Br-RT), its impact on chimeric antigen receptor T-cell therapy (CAR-T) efficacy and toxicity remains poorly characterized. We retrospectively reviewed patients with relapsed/refractory B-cell lymphomas (BCLs) who received Br-RT followed by CAR-T from 2018 to 2020 across 10 institutions. Br-RT toxicities were graded per Common Terminology Criteria for Adverse Events version 5.0, and cytokine release syndrome (CRS) and immune e…

  PublisherOA PDFDOI

• Epstein‑Barr virus‑associated primary central nervous system lymphoma in an immunosuppressed patient with a comorbid autoimmune disorder: A case report

  Experimental and Therapeutic Medicine · 2023-07-10 · 5 citations

  articleOpen access

  Patients with primary central nervous system lymphoma (PCNSL) typically present with non‑focal neurological symptoms, including disorientation, poor balance and memory loss with unifocal or multifocal periventricular lesions seen on MRI. Deviations from these characteristic findings can delay diagnosis and lead to additional diagnostic tests being needed. The present study reports a 68‑year‑old man with a recent varicella zoster infection and history of acetylcholine receptor antibody‑positive m…

  PublisherOA PDFDOI

Frequent coauthors

• Adam Kirn

  Florida International University

  51 shared

• Indira Chatterjee

  Case Western Reserve University

  51 shared

• Jennifer Amos

  University of Illinois Urbana-Champaign

  51 shared

• Kamran A. Ahmed

  Moffitt Cancer Center

  34 shared

• Arnold B. Etame

  Moffitt Cancer Center

  32 shared

• Mariano A. Garcia‐Blanco

  University of Virginia

  31 shared

• Peter Forsyth

  Moffitt Cancer Center

  31 shared

• Nicholas B. Figura

  Moffitt Cancer Center

  31 shared

Education

• Resident, Radiation Oncology

  Duke University School of Medicine

  2016

Awards & honors

• Javits Fellowship
• Mellon Fellowship

Similar researchers at Yale University

• Brad Inwoodh-39
• Egbert Bakkerh-24
• Noel Lenskih-21